Zentek Ltd. (NASDAQ:ZTEK – Get Rating) was the target of a large drop in short interest in December. As of December 30th, there was short interest totalling 5,700 shares, a drop of 75.8% from the December 15th total of 23,600 shares. Approximately 0.0% of the company's stock are short sold. Based on an average trading volume of 22,200 shares, the short-interest ratio is currently 0.3 days.
Institutional Investors Weigh In On Zentek
Several hedge funds and other institutional investors have recently made changes to their positions in the business. JPMorgan Chase & Co. acquired a new stake in shares of Zentek during the 1st quarter worth about $25,000. Scotia Capital Inc. increased its position in Zentek by 1.8% during the second quarter. Scotia Capital Inc. now owns 483,735 shares of the company's stock worth $872,000 after buying an additional 8,654 shares during the period. Cambridge Investment Research Advisors Inc. acquired a new position in Zentek during the first quarter worth approximately $32,000. Cutter & CO Brokerage Inc. acquired a new position in Zentek during the second quarter worth approximately $27,000. Finally, Bank of Montreal Can acquired a new position in Zentek during the first quarter worth approximately $199,000. Institutional investors and hedge funds own 0.71% of the company's stock.
Get
Zentek alerts:
Zentek Price Performance
Shares of NASDAQ ZTEK traded up $0.05 during midday trading on Tuesday, hitting $1.47. 200 shares of the company's stock were exchanged, compared to its average volume of 18,669. Zentek has a twelve month low of $1.28 and a twelve month high of $3.78. The firm's fifty day simple moving average is $1.59 and its 200-day simple moving average is $1.79.
Zentek (NASDAQ:ZTEK – Get Rating) last issued its earnings results on Monday, November 14th. The company reported ($0.03) earnings per share for the quarter. Zentek had a negative return on equity of 405.71% and a negative net margin of 1,617.24%.
Zentek Company Profile
(Get Rating)
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound.
Recommended Stories
- Get a free copy of the StockNews.com research report on Zentek (ZTEK)
- Is Dividend King PPG Industries A Buy Before Earnings?
- Shocking New Documentary Exposes The Two Men Destroying America
- 3 Dividend Stocks For Passive Income
- UnitedHealth Group Stock: Is This The Bottom?
- Tesla Stock Continues To Consolidate After A Bad Quarter
Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.
